![](https://etira.life/wp-content/uploads/2022/10/Annual-Meet-Feature-Image-495x400.jpg)
Etira founder Dr. Jung-Mo Ahn highlighted in local press
NewsDallas, Texas. October 31, 2022. We are pleased to share two news articles from Dallas that describe how our brilliant chemist and founder, Dr. Jung-Mo Ahn discovered ERX-41. In his words, Dr. Ahn describes the discovery of ERX-41 as “It’s…
![](https://etira.life/wp-content/uploads/2022/10/Oncology-thumbnail-495x400.jpg)
Oncology Times Highlights ERX-41
NewsDallas, Texas. October 10, 2022:etiraRx's lead drug candidate, ERX-41 has been highlighted in the most recent edition of Oncology Times. In an article entitled "Molecule Targets Vulnerability in Triple-Negative Breast Cancer," Dibash Kumar…